RESEARCHER PROFILE
Eiman A. Aleem
← Back to London South Bank University
E
London South Bank University
Eiman A. Aleem works in Acute Myeloid Leukemia Research, Cancer-related Molecular Pathways, Protein Kinase Regulation and GTPase Signaling, Microtubule and mitosis dynamics, T-cell and B-cell Immunology. Recorded institutional associations include London South Bank University.
70Publications
2,201Citations
21H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Cdk2 Knockout Mice Are Viable
2003 · 663 citationsCdc2–cyclin E complexes regulate the G1/S phase transition
2005 · 383 citationsTargeting cell cycle regulators in hematologic malignancies
2015 · 120 citationsDependence of Cisplatin-Induced Cell Death In Vitro and In Vivo on Cyclin-Dependent Kinase 2
2006 · 101 citationsIL-7 promotes T cell proliferation through destabilization of p27Kip1
2006 · 94 citationsCell Cycle Sibling Rivalry: Cdc2 Versus Cdk2
2005 · 87 citationsNanoparticle-mediated cancer cell therapy: basic science to clinical applications
2023 · 79 citationsβ -Glucans and their Applications in Cancer Therapy: Focus on human studies
2013 · 73 citationsUpregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis
2011 · 62 citationsDisulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
2017 · 56 citationsSchizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen
2012 · 49 citationsSerum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection
2011 · 45 citationsNuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage
2017 · 43 citationsCdk2 as a Master of S phase Entry: Fact or Fake?
2004 · 39 citationsPRKAR1A Inactivation Leads to Increased Proliferation and Decreased Apoptosis in Human B Lymphocytes
2006 · 39 citationsCdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
2009 · 36 citationsPicropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism
2014 · 32 citationsClinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis
2018 · 24 citationsMouse Models of Cell Cycle Regulators: New Paradigms
2006 · 23 citationsMultiple antitumor effects of picropodophyllin in colon carcinoma cell lines: Clinical implications
2011 · 22 citationsExopolysaccharide-peptide complex from oyster mushroom (Pleurotus ostreatus) protects against hepatotoxicity in rats
2020 · 21 citationsCDK2 Is Required By MYC to Induce Apoptosis
2006 · 20 citationsDownregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cells
2016 · 18 citationsHighlights on selected growth factors and their receptors as promising anticancer drug targets
2021 · 13 citationsCDK2 knockdown enhances head and neck cancer cell radiosensitivity
2013 · 11 citations
